NASDAQ · Drug Manufacturers - Specialty & Generic · USD

Caring Brands, Inc. (CABR) Stock Analysis

Caring Brands, Inc. (CABR) is a Drug Manufacturers - Specialty & Generic stock listed on NASDAQ and quoted in US Dollar.

CABR

$1.26

−$0.01 (−0.79%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CABR with… →

CABR Key Statistics

As of Sep 4, 2026

Trading

Open: $1.26
Previous Close: $1.27
Day's Range: 1.25–1.36
52-Week Range: 0.71–1.84
Volume: 5.30K

Valuation

Market Cap: $13.06M
P/E Ratio: unprofitable
EPS (ttm): −0.77

Financials (FY)

Revenue (FY): $4.22K+806.45%
Net Income (FY): −$6.28M
Profit margin: 0.00%
Shares Outstanding: 10.37M

Dividend and dates

Avg Volume: 75.97K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

CABR Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

Year	Return
2026 (partial year)	+46.85%
2025 (partial year)	+3.00%

As of September 4, 2026.

CABR Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$4.22K	−$6.28M	−148948.8%
2024	$465.00	−$1.52M	−326329.2%
2023	$20.42K	−$128.09K	−627.2%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$4.22K	$2.34K	−$3.39M	−$6.28M	−148948.8%
2024	$465.00	−$1.61K	−$1.53M	−$1.52M	−326329.2%
2023	$20.42K	−$98.45K	−$151.39K	−$128.09K	−627.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

CABR Valuation vs Drug Manufacturers - Specialty & Generic Median

Median of 103 stocks

Metric	CABR	Drug Manufacturers - Specialty & Generic median	vs median
Profit margin	0.00%	−3.14%	3.1 pts above

Medians across 103 Drug Manufacturers - Specialty & Generic stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Caring Brands, Inc. (CABR) is capitalised at $13.06M on the latest close. The company sits in the Healthcare sector, in the Drug Manufacturers - Specialty & Generic industry. Headcount on file is 3.

The most recent close on file for CABR is $1.26, dated September 4, 2026. That is −$0.01 (−0.79%) against the previous close. The 52-week range on file runs from $0.71 to $1.84. The latest close sits 77.46% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $4.22K. Against the prior fiscal year total of $465.00, that is a change of +806.45%. The same year closed with a net loss of $6.28M. Profit margin runs at 0%. That is 3.1 percentage points above the Drug Manufacturers - Specialty & Generic median of −3.14%. Earnings per share on a trailing basis come to −0.77.

Across the 3 fiscal years on file, revenue moves from $20.42K in 2023 to $4.22K in 2025. Of those 3 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative.

The stored price history starts on November 17, 2025, and the total return since then is +51.26%.

Growth & Income

The record shows no dividend for CABR.

2026 is still running; the price is +46.85% year to date.

Peer Comparison

Caring Brands, Inc. (CABR) operates in the Drug Manufacturers - Specialty & Generic industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Caring Brands, Inc.	CABR	$13.06M	—
Takeda Pharmaceutical Company Limited	TAK	$58.92B	—
Teva Pharmaceutical Industries Limited	TEVA	$42.37B	60.6
Haleon plc	HLN	$42.22B	20.0

The Drug Manufacturers - Specialty & Generic industry average P/E ratio is 19.3x. Caring Brands, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Drug Manufacturers - Specialty & Generic Stocks

TAK

Takeda Pharmaceutical Company Limited

$58.92B

TEVA

Teva Pharmaceutical Industries Limited

$42.37B

HLN

Haleon plc

$42.22B

ZTS

Zoetis Inc.

$31.33B

UTHR

United Therapeutics Corporation

$20.91B

VTRS

Viatris Inc.

$19.39B

View all Drug Manufacturers - Specialty & Generic stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

JNJ

Johnson & Johnson

$663.28B

ABBV

AbbVie Inc.

$453.19B

MRK

Merck & Co., Inc.

$370.89B

UNH

UnitedHealth Group Incorporated

$356.47B

View all Healthcare stocks →

About Caring Brands, Inc.

Caring Brands, Inc., a wellness consumer products company, provides over-the-counter and cosmetic consumer products. It offers Hair Enzyme Booster (JW-700) for the treatment of hair growth; Photocil for the treatment of psoriasis and vitiligo; and CB-101 (Eczema Treatment) for atopic dermatitis (eczema). The company also offers NoStingz for the protection from jellyfish, sea lice, and UVA/UVB rays; and GoldN for Ebola diagnostics, as well as provides vitiligo solutions and women's sexual wellness products. Caring Brands, Inc., was incorporated in 2020 and is based in Fort Pierce, Florida.

Visit website →